OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA PATIENTS WITH ACTIVE REFRACTORY DISEASE BEFORE TRANSPLANT

Introduction: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is the most potent post-remission treatment for Acute Myeloid Leukemia (AML) to reduce relapse rates. However, achieving Complete Remission (CR) and Minimal Residual Disease (MRD) before transplant are crucial predictors of rela...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	FS Azevedo, VC Molla, PHA Moraes, EL Rosa, RS Szor, CC Justino, CD Liz, AM Fonseca, C Arrais
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2024-10-01
Ráidu:	Hematology, Transfusion and Cell Therapy
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S2531137924020716
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!